REG1V Revenio Group Oyj
11.04EUR-2.99%Mkt Cap: 416.98M $P/E: 26.931d ago
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap416.98M USD
Enterprise Value633.04M USD
Revenue (TTM)135.16M USD
Gross Profit84.57M USD
Net Income (TTM)18.93M USD
Revenue/Share4.67 EUR
Last Price11.04 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees765
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009010912
Valuation
P/E (Trailing)26.93
P/E (Forward)12.32
PEG6.37
EV/EBITDA28.98
EV/Revenue4.68
P/S3.18
P/B2.28
EPS (TTM)0.41
EPS (Forward)0.92
52W Range
10.364% of range25.85
52W High25.85 EUR
52W Low10.36 EUR
Profitability
Gross Margin70.94%
Oper. Margin6.05%
EBITDA Margin16.16%
Profit Margin15.88%
ROE15.18%
ROA11.56%
Growth
Revenue Growth49.80%
Earnings Growth-82.80%
Cash Flow & Leverage
Operating CF32.86M USD
CapEx (TTM)4.54M USD
FCF Margin-10.13%
FCF Yield-3.28%
Net Debt261.96M USD
Net Debt/EBITDA11.99
Balance Sheet
Debt/Equity0.10
Current Ratio0.58
Quick Ratio0.34
Book Value/Sh4.98 EUR
Cash/Share0.59 EUR
Dividends
Fwd Div Rate0.33 EUR
Trail. Div Rate0.44 EUR
Div. Yield0.00%
5Y Avg Yield1.11%
Payout Ratio0.00%
Ex-Div DateApr 11, 2025
Pay Date—
Splits
Last Split3:1
Split DateMar 21, 2018
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.37 EUR
Upside (mean)+48.2%
Target Range15.60 EUR – 17.00 EUR
15.60+48.2% to mean17.00
# Analysts3
Ownership
Shares Out.34.75M
Float27.97M
Insiders9.68%
Institutions50.71%
Technical
SMA 5012.95 (-14.7%)
SMA 20015.83 (-30.3%)
Beta0.92
S&P 52W Chg16.45%
Avg Vol (30d)153.46K
Avg Vol (10d)81.98K
Technical Indicators
RSI (14)39.9
MACD-0.7541
MACD Signal-0.7513
MACD Hist.-0.0029
BB Upper14.11 EUR
BB Middle11.72 EUR
BB Lower9.328 EUR
BB Width40.83%
ATR (14)0.5831 EUR
Vol Ratio (20d)0.66x